ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
6
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,695
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Safety and tolerability of omalizumab (Xolair), a recombinant humanized monoclonal anti-IgE antibody
Author(s):
N Gupta
,
Y Deniz
Publication date:
2005
Read this article at
ScienceOpen
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Anti-Trafficking Review
Data availability:
ScienceOpen disciplines:
Medicine
Comments
Comment on this article
Sign in to comment
Similar content
2,695
Omalizumab (XOLAIR®) : un anticorps monoclonal humanisé à risque ?
Authors:
G Veyrac
,
A.L. Ruellan
,
A Pipet
…
PRS30 Identifying the Patient Population Where Treatment of Severe Allergic Asthma with Omalizumab (XOLAIR®) Exhibits Optimal Cost-Effectiveness in Australia
Authors:
D Tilden
,
S. Cottrell
,
L. Tocchini
…
Enrollment Update of the Epidemiologic Study of Xolair: Evaluating the Long-Term Safety and Clinical Effectiveness in Patients with Moderate to Severe Asthma (EXCELS)
Authors:
M.K. Miller
,
J.H. Lee
,
D. Forer
…
See all similar